| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cocrystal Pharma, Inc. | Director | Stock Options (Right to Buy) | 16,410 | 09 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| COCP | Cocrystal Pharma, Inc. | 09 Jan 2026 | 1 | $0 | 4 | Director | 13 Jan 2026, 16:10 |
| COCP | Cocrystal Pharma, Inc. | 09 Oct 2024 | 1 | $0 | 4 | Director | 11 Oct 2024, 16:05 |
| COCP | Cocrystal Pharma, Inc. | 18 Jul 2023 | 1 | $0 | 4 | Director | 20 Jul 2023, 16:05 |
| COCP | Cocrystal Pharma, Inc. | 25 Jul 2022 | 1 | $0 | 4 | Director | 03 Aug 2022, 16:51 |
| /report/000110465921126890-japour-anthony-j-2021-10-14 | Sanaby Health Acquisition Corp. I | 14 Oct 2021 | 0 | $0 | 3 | Director | 15 Oct 2021, 20:33 |
| COCP | Cocrystal Pharma, Inc. | 16 Jul 2021 | 1 | $0 | 4 | Director | 20 Jul 2021, 16:05 |